STAT3 and leukemia: Our group has accumulated a wealth of experience in previous studies on RIG-I, such as RIG-I inhibiting the phosphorylation of STAT3 and AKT, which regulate immune homoeostasis and suppress leukaemia (Li et al, 2014; Yang et al, 2017).